Literature DB >> 29150892

Expanding the neurodevelopmental phenotype of PURA syndrome.

Bo Hoon Lee1, Margot R F Reijnders2, Oluwatobi Abubakare3, Emily Tuttle3, Brynn Lape3, Kelly Q Minks1, Christopher Stodgell4, Loisa Bennetto5, Jennifer Kwon1,6,7, Chin-To Fong6, Karen W Gripp8, Eric D Marsh9, Wendy E Smith10, Ahm M Huq11, Stephanie A Coury12, Wen-Hann Tan12, Orestes Solis3, Rupal I Mehta3,7, Richard J Leventer13, Diana Baralle14,15, David Hunt15, Alex R Paciorkowski1,3,6,16.   

Abstract

PURA syndrome is a recently described developmental encephalopathy presenting with neonatal hypotonia, feeding difficulties, global developmental delay, severe intellectual disability, and frequent apnea and epilepsy. We describe 18 new individuals with heterozygous sequence variations in PURA. A neuromotor disorder starting with neonatal hyptonia, but ultimately allowing delayed progression to walking, was present in nearly all individuals. Congenital apnea was present in 56% during infancy, but all cases in this cohort resolved during the first year of life. Feeding difficulties were frequently reported, with gastrostomy tube placement required in 28%. Epilepsy was present in 50% of the subjects, including infantile spasms and Lennox-Gastaut syndrome. Skeletal complications were found in 39%. Disorders of gastrointestinal motility and nystagmus were also recurrent features. Autism was diagnosed in one individual, potentially expanding the neurodevelopmental phenotype associated with this syndrome. However, we did not find additional PURA sequence variations in a cohort of 120 subjects with autism. We also present the first neuropathologic studies of PURA syndrome, and describe chronic inflammatory changes around the arterioles within the deep white matter. We did not find significant correlations between mutational class and severity, nor between location of the sequence variation in PUR repeat domains. Further studies are required in larger cohorts of subjects with PURA syndrome to clarify these genotype-phenotype associations.
© 2017 Wiley Periodicals, Inc.

Entities:  

Keywords:  PURA; congenital apnea; deletion 5q31.3; epilepsy; intellectual disability

Mesh:

Substances:

Year:  2017        PMID: 29150892      PMCID: PMC5821266          DOI: 10.1002/ajmg.a.38521

Source DB:  PubMed          Journal:  Am J Med Genet A        ISSN: 1552-4825            Impact factor:   2.802


  13 in total

1.  5q31.3 Microdeletion syndrome: clinical and molecular characterization of two further cases.

Authors:  Natasha Brown; Trent Burgess; Robin Forbes; George McGillivray; Andrew Kornberg; Simone Mandelstam; Zornitza Stark
Journal:  Am J Med Genet A       Date:  2013-08-15       Impact factor: 2.802

2.  Mutations in PURA cause profound neonatal hypotonia, seizures, and encephalopathy in 5q31.3 microdeletion syndrome.

Authors:  Seema R Lalani; Jing Zhang; Christian P Schaaf; Chester W Brown; Pilar Magoulas; Anne Chun-Hui Tsai; Areeg El-Gharbawy; Klaas J Wierenga; Dennis Bartholomew; Chin-To Fong; Tina Barbaro-Dieber; Mary K Kukolich; Lindsay C Burrage; Elise Austin; Kory Keller; Matthew Pastore; Fabio Fernandez; Timothy Lotze; Angus Wilfong; Gabriela Purcarin; Wenmiao Zhu; William J Craigen; Marianne McGuire; Mahim Jain; Erin Cooney; Mahshid Azamian; Matthew N Bainbridge; Donna M Muzny; Eric Boerwinkle; Richard E Person; Zhiyv Niu; Christine M Eng; James R Lupski; Richard A Gibbs; Arthur L Beaudet; Yaping Yang; Meng C Wang; Fan Xia
Journal:  Am J Hum Genet       Date:  2014-10-16       Impact factor: 11.025

3.  Mutations in TCF4, encoding a class I basic helix-loop-helix transcription factor, are responsible for Pitt-Hopkins syndrome, a severe epileptic encephalopathy associated with autonomic dysfunction.

Authors:  Jeanne Amiel; Marlene Rio; Loic de Pontual; Richard Redon; Valerie Malan; Nathalie Boddaert; Perrine Plouin; Nigel P Carter; Stanislas Lyonnet; Arnold Munnich; Laurence Colleaux
Journal:  Am J Hum Genet       Date:  2007-03-23       Impact factor: 11.025

4.  Molecular findings among patients referred for clinical whole-exome sequencing.

Authors:  Yaping Yang; Donna M Muzny; Fan Xia; Zhiyv Niu; Richard Person; Yan Ding; Patricia Ward; Alicia Braxton; Min Wang; Christian Buhay; Narayanan Veeraraghavan; Alicia Hawes; Theodore Chiang; Magalie Leduc; Joke Beuten; Jing Zhang; Weimin He; Jennifer Scull; Alecia Willis; Megan Landsverk; William J Craigen; Mir Reza Bekheirnia; Asbjorg Stray-Pedersen; Pengfei Liu; Shu Wen; Wendy Alcaraz; Hong Cui; Magdalena Walkiewicz; Jeffrey Reid; Matthew Bainbridge; Ankita Patel; Eric Boerwinkle; Arthur L Beaudet; James R Lupski; Sharon E Plon; Richard A Gibbs; Christine M Eng
Journal:  JAMA       Date:  2014-11-12       Impact factor: 56.272

5.  MEF2C haploinsufficiency caused by either microdeletion of the 5q14.3 region or mutation is responsible for severe mental retardation with stereotypic movements, epilepsy and/or cerebral malformations.

Authors:  N Le Meur; M Holder-Espinasse; S Jaillard; A Goldenberg; S Joriot; P Amati-Bonneau; A Guichet; M Barth; A Charollais; H Journel; S Auvin; C Boucher; J-P Kerckaert; V David; S Manouvrier-Hanu; P Saugier-Veber; T Frébourg; C Dubourg; J Andrieux; D Bonneau
Journal:  J Med Genet       Date:  2009-07-09       Impact factor: 6.318

6.  FOXG1 is responsible for the congenital variant of Rett syndrome.

Authors:  Francesca Ariani; Giuseppe Hayek; Dalila Rondinella; Rosangela Artuso; Maria Antonietta Mencarelli; Ariele Spanhol-Rosseto; Marzia Pollazzon; Sabrina Buoni; Ottavia Spiga; Sara Ricciardi; Ilaria Meloni; Ilaria Longo; Francesca Mari; Vania Broccoli; Michele Zappella; Alessandra Renieri
Journal:  Am J Hum Genet       Date:  2008-06-19       Impact factor: 11.025

7.  Familial recurrences of FOXG1-related disorder: Evidence for mosaicism.

Authors:  Kelly Q McMahon; Apostolos Papandreou; Mandy Ma; Brenda J Barry; Ghayda M Mirzaa; William B Dobyns; Richard H Scott; Natalie Trump; Manju A Kurian; Alex R Paciorkowski
Journal:  Am J Med Genet A       Date:  2015-09-14       Impact factor: 2.802

Review 8.  Breathing challenges in Rett syndrome: lessons learned from humans and animal models.

Authors:  Jan-Marino Ramirez; Christopher Scott Ward; Jeffrey Lorenz Neul
Journal:  Respir Physiol Neurobiol       Date:  2013-06-28       Impact factor: 1.931

9.  Whole exome sequencing in family trios reveals de novo mutations in PURA as a cause of severe neurodevelopmental delay and learning disability.

Authors:  David Hunt; Richard J Leventer; Cas Simons; Ryan Taft; Kathryn J Swoboda; Mary Gawne-Cain; Alex C Magee; Peter D Turnpenny; Diana Baralle
Journal:  J Med Genet       Date:  2014-10-23       Impact factor: 6.318

10.  De novo mutations in PURA are associated with hypotonia and developmental delay.

Authors:  Akemi J Tanaka; Renkui Bai; Megan T Cho; Kwame Anyane-Yeboa; Priyanka Ahimaz; Ashley L Wilson; Fran Kendall; Beverly Hay; Timothy Moss; Monica Nardini; Mislen Bauer; Kyle Retterer; Jane Juusola; Wendy K Chung
Journal:  Cold Spring Harb Mol Case Stud       Date:  2015-10
View more
  8 in total

1.  Complex Movement Disorders in a Boy with PURA Syndrome.

Authors:  Shan-Ju Lin; Yung-Feng Lin; Cheng-Hsien Tsai; Chiung-Hui Huang; Fangyi Ho; Shih-Feng Tsai; Wei-Sheng Lin
Journal:  Mov Disord Clin Pract       Date:  2021-07-08

2.  A novel de novo mutation in the PURA gene associated with a new clinical finding: large brainstem.

Authors:  María Elena Rodríguez-García; Francisco Javier Cotrina-Vinagre; Elena Arranz-Canales; Ana Martínez de Aragón; Laura Hernández-Sánchez; Fátima Rodríguez-Fornés; Patricia Carnicero-Rodríguez; Montserrat Morales-Conejo; Elena Martín-Hernández; Francisco Martínez-Azorín
Journal:  J Genet       Date:  2020       Impact factor: 1.166

3.  Novel frameshift mutation in PURA gene causes severe encephalopathy of unclear cause.

Authors:  Lucía Spangenberg; Rosario Guecaimburú; Alejandra Tapié; Susana Vivas; Soledad Rodríguez; Martín Graña; Hugo Naya; Víctor Raggio
Journal:  Mol Genet Genomic Med       Date:  2021-03-22       Impact factor: 2.183

4.  Expanding the PURA syndrome phenotype: A child with the recurrent PURA p.(Phe233del) pathogenic variant showing similarities with cutis laxa.

Authors:  Valeria Cinquina; Claudia Ciaccio; Marina Venturini; Riccardo Masson; Marco Ritelli; Marina Colombi
Journal:  Mol Genet Genomic Med       Date:  2020-12-04       Impact factor: 2.183

5.  Neonatal PURA syndrome: a case report and literature review.

Authors:  Ying Liu; Rui Liu; Tong Xu; Yu-Xin Zhou; Shuang-Chuan Zhang
Journal:  Transl Pediatr       Date:  2021-01

6.  PURA-Related Developmental and Epileptic Encephalopathy: Phenotypic and Genotypic Spectrum.

Authors:  Katrine M Johannesen; Elena Gardella; Cathrine E Gjerulfsen; Allan Bayat; Rob P W Rouhl; Margot Reijnders; Sandra Whalen; Boris Keren; Julien Buratti; Thomas Courtin; Klaas J Wierenga; Bertrand Isidor; Amélie Piton; Laurence Faivre; Aurore Garde; Sébastien Moutton; Frédéric Tran-Mau-Them; Anne-Sophie Denommé-Pichon; Christine Coubes; Austin Larson; Michael J Esser; Juan Pablo Appendino; Walla Al-Hertani; Beatriz Gamboni; Alejandra Mampel; Lía Mayorga; Alessandro Orsini; Alice Bonuccelli; Agnese Suppiej; Julien Van-Gils; Julie Vogt; Simona Damioli; Lucio Giordano; Stephanie Moortgat; Elaine Wirrell; Sarah Hicks; Usha Kini; Nathan Noble; Helen Stewart; Shailesh Asakar; Julie S Cohen; SakkuBai R Naidu; Ashley Collier; Eva H Brilstra; Mindy H Li; Casey Brew; Stefania Bigoni; Davide Ognibene; Elisa Ballardini; Claudia Ruivenkamp; Raffaella Faggioli; Alexandra Afenjar; Diana Rodriguez; David Bick; Devorah Segal; David Coman; Boudewijn Gunning; Orrin Devinsky; Laurie A Demmer; Theresa Grebe; Dario Pruna; Ida Cursio; Lynn Greenhalgh; Claudio Graziano; Rahul Raman Singh; Gaetano Cantalupo; Marjolaine Willems; Sangeetha Yoganathan; Fernanda Góes; Richard J Leventer; Davide Colavito; Sara Olivotto; Barbara Scelsa; Andrea V Andrade; Kelly Ratke; Farha Tokarz; Atiya S Khan; Clothilde Ormieres; William Benko; Karen Keough; Sotirios Keros; Shanawaz Hussain; Ashlea Franques; Felicia Varsalone; Sabine Grønborg; Cyril Mignot; Delphine Heron; Caroline Nava; Arnaud Isapof; Felippe Borlot; Robyn Whitney; Anne Ronan; Nicola Foulds; Marta Somorai; John Brandsema; Katherine L Helbig; Ingo Helbig; Xilma R Ortiz-González; Holly Dubbs; Antonio Vitobello; Mel Anderson; Dominic Spadafore; David Hunt; Rikke S Møller; Guido Rubboli
Journal:  Neurol Genet       Date:  2021-11-15

7.  Expanding the PURA syndrome phenotype with manifestations in a Japanese female patient.

Authors:  Yuya Fukuda; Yoshimasa Kudo; Makoto Saito; Tadashi Kaname; Tohru Oota; Reikichi Shoji
Journal:  Hum Genome Var       Date:  2022-04-19

8.  PURα Promotes the Transcriptional Activation of PCK2 in Oesophageal Squamous Cell Carcinoma Cells.

Authors:  Yan Sun; Jiajia Gao; Zongpan Jing; Yan Zhao; Yulin Sun; Xiaohang Zhao
Journal:  Genes (Basel)       Date:  2020-10-31       Impact factor: 4.096

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.